RPA
DGX icon

Redwood Park Advisors’s Quest Diagnostics DGX Stock Holding History

Redwood Park Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424 Hold
2
– – ﹤0.01% 310
2026
Q1 		$392 Sell
2
-2
-50% -$389 ﹤0.01% 287
2025
Q4 		$695 Hold
4
– – ﹤0.01% 267
2025
Q3 		$763 Hold
4
– – ﹤0.01% 264
2025
Q2 		$719 Buy
4
+1
+33% +$174 ﹤0.01% 261
2025
Q1 		$508 Hold
3
– – ﹤0.01% 295
2024
Q4 		$453 Buy
+3
New +$467 ﹤0.01% 311

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Redwood Park Advisors's DGX Position: Q2 2026 in Review

Redwood Park Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2 shares worth $424. The position accounts for ﹤0.01% of the portfolio, ranked #310.

Redwood Park Advisors first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $763 in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Redwood Park Advisors held 2 shares of Quest Diagnostics worth $424 as of Q2 2026.
  • Redwood Park Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Redwood Park Advisors's portfolio in Q2 2026, its #310 holding.
  • Redwood Park Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Redwood Park Advisors's Quest Diagnostics position peaked at $763 in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.